General information about company | |
Name of The Company | THIRUMALAI CHEMICALS LTD. |
BSE Scrip Code | 500412 |
NSE Symbol | TIRUMALCHM |
MSE Symbol | NA |
Date of Start of Financial Year | 01-04-2021 |
Date of End of Financial Year | 31-03-2022 |
Reporting Period | Second half yearly |
Date of Start of Reporting Period | 01-10-2021 |
Date of End of Reporting Period | 31-03-2022 |
Level of rounding used in financial results | Lakhs |
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? | Yes |
Related party transactions | |||||||||||||||||||
A. Details of related party | Sr | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | ||
Name of the related party | Mr. R.Parthasarathy | Mrs. Ramya Bharathram | Mr. P Mohanachandra Nair | Mr. C.G. Sethuram | Mr. Sanjay Sinha | Mr. T. Rajagopalan | Ultramarine and Pigments Limited | Thirumalai Charity Trust | Mr. R. Ravi Shankar | Mr. Raj Kataria | Mr. Arun Ramanathan | Mr. Rajeev M. Pandia | Mrs. Bhama Krishnamurthy | Mr. Dhruv Moondhra | Mr N SUBRAMANIAN | Mr R Sampath | |||
Categories of related parties | Key management personnel of entity or parent | Key management personnel of entity or parent | Key management personnel of entity or parent | Key management personnel of entity or parent | Key management personnel of entity or parent | Key management personnel of entity or parent | Promoters | Other related party | Other related party | Other related party | Other related party | Other related party | Other related party | Other related party | Other related party | Promoters Group | |||
description of relationship | Managing Director | Managing Director | Whole-time Director | Group CEO | CEO | Company Secretary | Corporate | Trust | Independent Director | Independent Director | Independent Director | Independent Director | Independent Director | Independent Director | Independent Director | Non-Executive and Non-Independent Director | |||
PAN of related party | AAHPP7475K | AGDPB4141J | AADPN9746R | AALPS5433Q | AAMPS2498C | AADPR4658N | AAACU0718Q | AAATT0087A | AAAPR3996E | AAPPK0522Q | ABMPR1919A | AAEPP3004D | AAPPK0269A | AGQPM2062C | AAAPS7668E | AALPS9616D | |||
CIN of related party | |||||||||||||||||||
B. Details of related party transactions | Purchase of goods and services | 0.7 | |||||||||||||||||
Sale of goods and services | |||||||||||||||||||
Purchase of fixed assets | |||||||||||||||||||
Sale of fixed assets | |||||||||||||||||||
Rendering of services | 497.16 | 337.71 | 41.67 | 109.36 | 126.93 | 19.69 | 22.85 | 5 | 3.2 | 3.2 | 4 | 3.4 | 3.94 | 0.6 | 4.6 | ||||
Receiving of services | 7.85 | 4.74 | |||||||||||||||||
Leases | |||||||||||||||||||
Loans and advances given | |||||||||||||||||||
Loans and advances taken | |||||||||||||||||||
Loans and advances given that are repaid | |||||||||||||||||||
Loans and advances taken that are repaid | |||||||||||||||||||
Deposits placed | |||||||||||||||||||
Deposits taken | |||||||||||||||||||
Transfer of research & development | |||||||||||||||||||
Transfers under lease agreement | |||||||||||||||||||
Equity investment | |||||||||||||||||||
Impairment in equity investment | |||||||||||||||||||
Expense for bad or doubtful debts | |||||||||||||||||||
Guarantees or collateral given | |||||||||||||||||||
Guarantees or collateral taken | |||||||||||||||||||
Interest income | |||||||||||||||||||
Interest paid | |||||||||||||||||||
Dividend income | |||||||||||||||||||
Dividend paid | |||||||||||||||||||
Management contracts including for deputation of employees | |||||||||||||||||||
Settlement of liabilities by entity on behalf of related party | |||||||||||||||||||
Remuneration | Short term employee benefits | ||||||||||||||||||
Post employment benefits | |||||||||||||||||||
Other long-term benefits | |||||||||||||||||||
Termination benefits | |||||||||||||||||||
Share based payments | |||||||||||||||||||
Others | 221 | 24.05 | 19.31 | 19.31 | 18.12 | 19.31 | 18.13 | 8.88 | 22.87 | ||||||||||
C. Outstanding balances | Receivables | Secured | |||||||||||||||||
Un Secured | 4.28 | ||||||||||||||||||
Payables | Secured | ||||||||||||||||||
Un Secured | 0.12 | 0.18 | |||||||||||||||||
Loans and advances given | Secured | ||||||||||||||||||
Un Secured | |||||||||||||||||||
Loans and advances taken | Secured | ||||||||||||||||||
Un Secured | |||||||||||||||||||
Deposits placed | Secured | ||||||||||||||||||
Un Secured | 14 | ||||||||||||||||||
Deposits taken | Secured | ||||||||||||||||||
Un Secured | |||||||||||||||||||
Guarantees or collateral given | Secured | ||||||||||||||||||
Un Secured | |||||||||||||||||||
Guarantees or collateral taken | Secured | ||||||||||||||||||
Un Secured | |||||||||||||||||||
Investment in equity | Secured | ||||||||||||||||||
Un Secured | |||||||||||||||||||
Provision for doubtful debt | Secured | ||||||||||||||||||
Un Secured | |||||||||||||||||||
Note | Remuneration | Remuneration | Remuneration | Remuneration | Remuneration | Remuneration | - | Contributed made towards for carrying out CSR activities shown under Others | Sitting fees paid shown under Rendering of Services and share of NED's Commission receivable for FY 2021-22 shown under Others. | Sitting fees paid shown under Rendering of Services and share of NED's Commission receivable for FY 2021-22 shown under Others. | Sitting fees paid shown under Rendering of Services and share of NED's Commission receivable for FY 2021-22 shown under Others. | Sitting fees paid shown under Rendering of Services and share of NED's Commission receivable for FY 2021-22 shown under Others. | Sitting fees paid shown under Rendering of Services and share of NED's Commission receivable for FY 2021-22 shown under Others. | Sitting fees paid shown under Rendering of Services and share of NED's Commission receivable for FY 2021-22 shown under Others. | Sitting fees paid shown under Rendering of Services and share of NED's Commission receivable for FY 2021-22 shown under Others. | Sitting fees paid shown under Rendering of Services and share of NED's Commission receivable for FY 2021-22 shown under Others. |